73: Bead-Based Assays: The Power of High-Throughput Screening w/ Sebastian Giehring - Part 1

Ready to revolutionize your lab work? Join us as we dive deep into bead-based assays with Sebastian Giehring, CEO and founder of PAIA Biotech. Discover how these tiny beads are making a massive impact on biotech research and development — for titer, glycan, and aggreation screening — and how this developability screening platform can enhance your antibody discovery, antibody engineering and lead optimization. In this episode, you’ll learn: Speed and Simplicity: How bead-based assays offer unmatched throughput and ease of use, allowing you to analyze hundreds of samples in just a few steps. Versatile Applications: The diverse applications of bead-based assays in cell development, bioprocessing, and antibody discovery, helping streamline workflows and enhance innovation. Early Screening Advantages: The benefits of bead-based assays in early-stage process development, enabling quick decision-making with less detailed but rapid results. Tune in to uncover how these assays can transform your biotech research and push the boundaries of what's possible! Connect with Sebastian Giehring: LinkedIn: https://www.linkedin.com/in/sebastian-giehring-6ba1992 PAIA Biotech: https://www.paiabio.com Next Steps: Book a free assessment to help you get started with the design of your next experiment at https://bruehlmann-consulting.com Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at [email protected] Support the show